Annual medical and indirect costs of various diseases in the United States.
Source: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Appendix C. The Economic Cost of Pain in the US. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Washington (DC): National Academies Press (US); 2011
CombiGene’s lead project CG01 has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 823282
The peptide-based pain project COZY01 has received funding from the Eurostars-3 programme, co-financed by the European Union's research and innovation programme Horizon Europe. Project ID: 4408
CombiGene is a member of ATMP Sweden, for more information visit https://atmpsweden.se/
CombiGene is supporting CCRM Nordic and Jan Nilsson is chairman of the Board of Directors.
Within the framework of the epilepsy project CG01, CombiGene has been collaborating with Lund University and the University of Copenhagen for many years. In recent years, CombiGene has also established collaboration regarding the preclinical development of the lipodystrophy project CGT2 with Stockholm University, University Medical Center Hamburg-Eppendorf and University of Michigan Medical School. The pain program COZY originates from academic research at Copenhagen University.